𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RS 86 in the treatment of alzheimer's disease: Cognitive and biological effects

✍ Scribed by Eric Hollander; Michael Davidson; Richard C. Mohs; Thomas B. Horvath; Bonnie M. Davis; Zvi Zemishlany; Kenneth L. Davis

Book ID
118317497
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
939 KB
Volume
22
Category
Article
ISSN
0006-3223

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical trials with the cholinergic dru
Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)
✍ Albert Wettstein; RenΓ© Spiegel πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 216 KB

The muscarinic agonist RS 86 was administered to patients with Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) in a series of controlled clinical trials. Daily doses were up to 3.0 mg orally for a maximum duration of 18 weeks. RS 86 produced typical peripheral cholinergic e